Synthetic peptide from the N terminal region of human CaMKIV.
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
Our Abpromise guarantee covers the use of ab75874 in the following tested applications.
|WB||1/1000 - 1/2000. Predicted molecular weight: 52 kDa.|
|ICC||1/100 - 1/250.|